BIT is generating quite a bit of interest at the moment. I had a look at the HepDART presentation (see link below) and did a Fishers Exact Test (stats) for small numbers on the data at 12 weeks. Selected BIT225 400mg plus SOC versus placebo plus SOC. The result is >0.5 - nowhere near a statistically significant difference. So I'd be cautious betting the shop on BIT atm. Numbers in the study are far too small to draw definite conclusions from. So beware of the hype atm. To be fair, the study was not designed to have the power needed to give a yes/no answer on efficacy. Looking somewhat promising but a way to go yet unless the pending HIV study results are truly outstanding.
Antiviral activity and tolerability of BIT225 plus pegylated interferon alfa-2b and weight-based ribavirin for 28 days in HCV treatment-naïve, genotype 1, mono-infected patients
- Forums
- ASX - By Stock
- BIT
- hepdart paper - data analysis
hepdart paper - data analysis
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.55M |
Open | High | Low | Value | Volume |
2.5¢ | 2.6¢ | 2.5¢ | $23.83K | 953.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 141000 | 2.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 36000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 141000 | 0.024 |
2 | 153913 | 0.023 |
5 | 4220555 | 0.022 |
1 | 250000 | 0.021 |
3 | 250000 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 36000 | 1 |
0.026 | 47379 | 2 |
0.027 | 161989 | 2 |
0.028 | 400000 | 2 |
0.029 | 305600 | 3 |
Last trade - 15.15pm 22/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online